Literature DB >> 28669958

[Expression of HDAC9 in different brain regions in mice with cerebral ischemic stroke].

Han-Tao Mai1, Tao Jiang, Ai-Wu Zhang, Tian-Ming Lv, Can-Hong Yang, Si-Si Qin.   

Abstract

OBJECTIVE: To investigate the expression and the subcellular localization of HDAC9 in different brain regions of mice after cerebral ischemic injury and explore the association between HDAC9 and ischemic stroke.
METHODS: Twenty-one male C57BL/6 mice were randomly divided into sham-operated group (n=9) and operated group (n=12). In the latter group, the mice with Zea-Longa neurological deficit scores of 2 or 3 following middle cerebral artery occlusion (MCAO) were assigned into MCAO group (n=9). Immunofluorescence was performed to investigate the subcellular localization of HDAC9 in the brain tissues on day 3 after MCAO. Western blotting and qRT-PCR were used to analyze the expression of HDAC9 in different regions of the brain. Results Immunofluorescence showed more intense HDAC9 expressions in the brain tissues around the infarct focus, and in the cells surrounding the infarct, HDAC9 expression was obviously increased in the cytoplasm and reduced in the cell nuclei. Compared with the other brain regions, the ipsilesional cortex with MCAO showed more abundant HDAC9 expressions at both the mRNA and protein levels (P<0.05).
CONCLUSION: HDAC9 may be closely related to cerebral ischemic injury and participate in the pathophysiological process of ischemic stroke.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28669958      PMCID: PMC6744151     

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  27 in total

1.  Histone deacetylase 9 as a negative regulator for choline acetyltransferase gene in NG108-15 neuronal cells.

Authors:  S Aizawa; K Teramoto; Y Yamamuro
Journal:  Neuroscience       Date:  2011-12-24       Impact factor: 3.590

Review 2.  Innate and adaptive immune response in stroke: Focus on epigenetic regulation.

Authors:  Antonietta Picascia; Vincenzo Grimaldi; Carmela Iannone; Andrea Soricelli; Claudio Napoli
Journal:  J Neuroimmunol       Date:  2015-10-21       Impact factor: 3.478

3.  Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action.

Authors:  Hyeon Ju Kim; Michael Rowe; Ming Ren; Jau-Shyong Hong; Po-See Chen; De-Maw Chuang
Journal:  J Pharmacol Exp Ther       Date:  2007-03-19       Impact factor: 4.030

4.  Stroke Induces Nuclear Shuttling of Histone Deacetylase 4.

Authors:  Haifa Kassis; Amjad Shehadah; Michael Chopp; Cynthia Roberts; Zheng Gang Zhang
Journal:  Stroke       Date:  2015-05-12       Impact factor: 7.914

5.  Deficiency of the stroke relevant HDAC9 gene attenuates atherosclerosis in accord with allele-specific effects at 7p21.1.

Authors:  Sepiede Azghandi; Caroline Prell; Sander W van der Laan; Manuela Schneider; Rainer Malik; Kerstin Berer; Norbert Gerdes; Gerard Pasterkamp; Christian Weber; Christof Haffner; Martin Dichgans
Journal:  Stroke       Date:  2014-11-11       Impact factor: 7.914

6.  High mobility group box 1 release from hepatocytes during ischemia and reperfusion injury is mediated by decreased histone deacetylase activity.

Authors:  John Evankovich; Sung W Cho; Ruilin Zhang; Jon Cardinal; Rajeev Dhupar; Lemeng Zhang; John R Klune; Jason Zlotnicki; Timothy Billiar; Allan Tsung
Journal:  J Biol Chem       Date:  2010-10-11       Impact factor: 5.157

Review 7.  Post-translational modifications regulate class IIa histone deacetylase (HDAC) function in health and disease.

Authors:  Rommel A Mathias; Amanda J Guise; Ileana M Cristea
Journal:  Mol Cell Proteomics       Date:  2015-01-23       Impact factor: 5.911

8.  Effects of transcranial direct current stimulation on hemichannel pannexin-1 and neural plasticity in rat model of cerebral infarction.

Authors:  T Jiang; R X Xu; A W Zhang; W Di; Z J Xiao; J Y Miao; N Luo; Y N Fang
Journal:  Neuroscience       Date:  2012-09-20       Impact factor: 3.590

Review 9.  Targeting histone deacetylases as a multifaceted approach to treat the diverse outcomes of stroke.

Authors:  Brett Langley; Camille Brochier; Mark A Rivieccio
Journal:  Stroke       Date:  2009-05-28       Impact factor: 7.914

10.  HDAC4 reduction: a novel therapeutic strategy to target cytoplasmic huntingtin and ameliorate neurodegeneration.

Authors:  Michal Mielcarek; Christian Landles; Andreas Weiss; Amyaouch Bradaia; Tamara Seredenina; Linda Inuabasi; Georgina F Osborne; Kristian Wadel; Chrystelle Touller; Rachel Butler; Janette Robertson; Sophie A Franklin; Donna L Smith; Larry Park; Paul A Marks; Erich E Wanker; Eric N Olson; Ruth Luthi-Carter; Herman van der Putten; Vahri Beaumont; Gillian P Bates
Journal:  PLoS Biol       Date:  2013-11-26       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.